Cooper Companies (The) (COO) balance sheet and financial health

Health Care Supplies · NASDAQ · Health Care

$60.72 -1.87% Close Nov 17, 2026 Live

TrendArc score 43 of 100 · Health 6.0 · Momentum 3.8 · Moat 5.8 · scored Nov 17, 2026 · How the score works

Cash and short-term investments less borrowings, July 31, 2026

$2.4 billion more borrowings than cash

Cooper Companies (The) held $155 million of cash and short-term investments against $2.5 billion of borrowings on July 31, 2026. In the fiscal year to October 2025 its operating income covered its interest 6.7 times.

Borrowings to equity

0.31

$2.54B of borrowings on $8.33B of equity, Jul 2026

Interest cover

6.7x

operating income over interest, fiscal year to October 2025

Return on invested capital

16.9%

latest quarter to July 2026, annualised; the stock card's measure

Cash and borrowings at each fiscal year end

$1.00B$2.00B$3.00B2016201720182019202020212022202320242025Cash and short-terminvestments $111MBorrowings $2.50B$1.00B$2.00B$3.00B20172019202120232025Cash and short-term investments $111MBorrowings $2.50B

What the balance sheet holdsJuly 31, 2026

Assets $12.7BSmaller items: other current assets $426MCash and short-term investments$155MReceivables$789MInventory$912MProperty, goodwill and other$10.4BFunded by $12.7BBorrowings$2.54BOther liabilities$1.80BMinority interests and other$200KShareholders' equity$8.33BAssets $12.7BCash and short-term investments$155MReceivables$789MInventory$912MOther current assets$426MProperty, goodwill and other$10.4BFunded by $12.7BBorrowings$2.54BOther liabilities$1.80BMinority interests and other$200KShareholders' equity$8.33B

"Other liabilities" is total liabilities less borrowings; "Property, goodwill and other" is total assets less the current assets and long-term investments; "Minority interests and other" is the rest of the funding (total assets less liabilities and shareholders' equity), mostly outside owners' stakes in subsidiaries.

Balance sheet, the last 10 fiscal year ends

In billions of US dollars, at each fiscal year end, named by the month it ended; the first column is the newest balance sheet on file. Borrowings are bonds, notes, loans and commercial paper; lease liabilities, operating and finance, are shown apart.
Fiscal year endLatest
Jul 2026
Oct 2025Oct 2024Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016
Assets
Cash and short-term investments0.20.10.10.10.10.10.10.10.10.10.1
Receivables0.80.80.70.60.60.50.40.40.40.30.3
Inventory0.90.80.80.70.60.60.60.50.50.50.4
Other current assets0.40.30.30.20.20.30.20.10.20.10.1
Total current assets2.32.12.01.71.51.51.31.21.11.00.9
Long-term investments0.00.00.00.00.00.00.00.00.00.00.0
Total assets12.712.412.311.711.59.66.76.36.14.94.5
Liabilities and equity
Current liabilities1.91.11.01.01.30.71.01.10.50.40.5
Borrowings2.52.52.62.62.71.51.81.82.01.21.3
Lease liabilities—0.30.30.30.3—0.3————
Total liabilities4.34.24.24.14.32.72.92.62.81.71.8
Shareholders' equity8.38.28.17.67.26.93.83.63.33.22.7
Financial health
Cash less borrowings-2.4-2.4-2.5-2.4-2.6-1.4-1.7-1.7-1.9-1.1-1.2
Borrowings to equity0.310.300.320.340.380.210.470.500.610.370.49
Interest cover—6.7x6.1x4.9x8.9x21.9x8.5x8.0x4.9x12.8x12.4x

Interest cover is operating income over interest expense, for full fiscal years. Minority interests and other is total assets less total liabilities and shareholders' equity (calculated by TrendArc). Company filings as standardised by Tiingo; borrowings and lease liabilities told apart with the lines the company files on SEC EDGAR, and a dash where the two cannot be told apart. Rebuilt nightly.

Cooper Companies (The) against its peers

CompanyCash less borrowingsBorrowings to equityInterest coverReturn on invested capital
Align TechnologyALGN +$1.14B 0.00 — 12.2%
Bio-TechneTECH +$150M 0.09 26.2x 5.1%
InsuletPODD -$353M 0.59 8.0x 22.4%
SterisSTE -$1.49B 0.27 18.1x 9.5%
RevvityRVTY -$2.04B 0.36 4.0x 2.5%
Charles River LaboratoriesCRL -$2.24B 0.76 0.2x 21.9%
Cooper Companies (The)COO -$2.39B 0.31 6.7x 16.9%
Zimmer BiometZBH -$7.10B 0.59 3.8x 4.0%
Baxter InternationalBAX -$7.49B 1.54 — 8.1%

Each company's newest balance sheet; borrowings leave lease liabilities out; interest cover for its newest fiscal year; return on invested capital is the stock card's measure. A dash where a measure does not apply.

Next

Follow Cooper Companies (The) with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Cooper Companies (The) from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.